Yabao Pharmaceutical Group Co., Ltd (600351.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Yabao Pharmaceutical Group Co., Ltd
—
Yabao Pharmaceutical Group Co., Ltd is led by CEO Wei Ren, employs 3,415 people, headquartered in Beijing, CN, publicly traded since 2002.
Yabao Pharmaceutical Group Co., Ltd (600351.SS) stock trades at $6.74 with a market capitalization of $4.85B. The stock is valued at a price-to-earnings (P/E) ratio of 14.91, price-to-book of 1.72, price-to-sales of 2.16. Over the past 52 weeks the stock has ranged between $5.60 and $7.45, and currently trades 9.5% below its 52-week high. It pays a dividend yielding 8.22%.
On profitability, Yabao Pharmaceutical Group Co., Ltd generates a return on equity (ROE) of 10.92%, an operating margin of 16.86%, a net profit margin of 14.39%.
Official website: www.yabao.com.cn
Yabao Pharmaceutical Group Co., Ltd (600351.SS) — frequently asked questions
What is Yabao Pharmaceutical Group Co., Ltd (600351.SS) stock price today?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) is currently trading at $6.74, down 2.74% today.
What is 600351.SS P/E ratio?
Yabao Pharmaceutical Group Co., Ltd's P/E ratio is 14.91. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 600351.SS return on equity (ROE)?
Yabao Pharmaceutical Group Co., Ltd's return on equity (ROE) is 10.92%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Yabao Pharmaceutical Group Co., Ltd's market cap?
Yabao Pharmaceutical Group Co., Ltd has a market capitalization of $4.85B.
Does 600351.SS pay a dividend?
Yes. Yabao Pharmaceutical Group Co., Ltd currently yields 8.22%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600351.SS carry?
Yabao Pharmaceutical Group Co., Ltd has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600351.SS's profit margin?
Yabao Pharmaceutical Group Co., Ltd reports a net profit margin of 14.39% — the share of revenue left after every cost, including tax and interest.
What sector is 600351.SS in?
Yabao Pharmaceutical Group Co., Ltd is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600351.SS listed on?
Yabao Pharmaceutical Group Co., Ltd trades on SHH under the ticker 600351.SS.
What is 600351.SS's 52-week range?
Over the last year Yabao Pharmaceutical Group Co., Ltd has traded between $5.60 and $7.45.
Related — Stocks
Popular Stocks
Screens 600351.SS currently matches
On the figures above, Yabao Pharmaceutical Group Co., Ltd passes the filters for 22 of our ready-made screens, among them Undervalued Stocks, Undervalued Dividend Stocks, High Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.